Association of WHSC1/NSD2 and T-cell infiltration with prostate cancer metastasis and prognosis

Abstract Progress in immunotherapy for prostate cancer (PCa) lags that for other cancers, mainly because of limited immune infiltration in PCa. This study aimed to assess the feasibility of NSD2 as an immunotherapeutic target in PCa. Immunohistochemistry was performed to evaluate the expression patt...

Full description

Bibliographic Details
Main Authors: Qiheng Li, Jiang Zhu, Yang Zhang, Yun Pan, Zhengjin Li, Min Wang, Yixuan Gao, Dongmei Feng, Xiaoyong He, Chunmei Zhang
Format: Article
Language:English
Published: Nature Portfolio 2023-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-48906-8
_version_ 1797397931659100160
author Qiheng Li
Jiang Zhu
Yang Zhang
Yun Pan
Zhengjin Li
Min Wang
Yixuan Gao
Dongmei Feng
Xiaoyong He
Chunmei Zhang
author_facet Qiheng Li
Jiang Zhu
Yang Zhang
Yun Pan
Zhengjin Li
Min Wang
Yixuan Gao
Dongmei Feng
Xiaoyong He
Chunmei Zhang
author_sort Qiheng Li
collection DOAJ
description Abstract Progress in immunotherapy for prostate cancer (PCa) lags that for other cancers, mainly because of limited immune infiltration in PCa. This study aimed to assess the feasibility of NSD2 as an immunotherapeutic target in PCa. Immunohistochemistry was performed to evaluate the expression pattern of NSD2 in 34 cases of benign prostatic hyperplasia (BPH), 36 cases of prostatic intraepithelial neoplasia (PIN), and 57 cases of PCa, including 19 cases of metastatic castration-resistant prostatic cancer (mCRPC). Single-cell RNA sequencing and gene set enrichment analysis (GSEA) were used to correlate NSD2 with certain downstream pathways. Furthermore, the Immuno-Oncology-Biological-Research (IOBR) software package was used to analyze the potential roles of NSD2 in the tumor microenvironment. We found that the positive expression rate of NSD2 increased progressively in BPH, PIN and PCa. mCRPC had the highest staining intensity for NSD2. High NSD2 expression was positively correlated with the infiltration level of CD4+ tumor-infiltrating lymphocytes (TILs) and negatively correlated with that of CD8+ TILs. Importantly, a new immune classification based on NSD2 expression and CD4+ TILs and CD8+ TILs was successfully used to stratify PCa patients based on OS.PSA and CD4+ TILs are independent risk factors for PCa bone metastasis. This study demonstrates a novel role for NSD2 in defining immune infiltrate on in PCa and highlights the great potential for its application in immunotherapy response evaluation for prostate malignancies.
first_indexed 2024-03-09T01:18:19Z
format Article
id doaj.art-24015f08d44241c5856b0ddc6255bcf0
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-09T01:18:19Z
publishDate 2023-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-24015f08d44241c5856b0ddc6255bcf02023-12-10T12:18:44ZengNature PortfolioScientific Reports2045-23222023-12-0113112010.1038/s41598-023-48906-8Association of WHSC1/NSD2 and T-cell infiltration with prostate cancer metastasis and prognosisQiheng Li0Jiang Zhu1Yang Zhang2Yun Pan3Zhengjin Li4Min Wang5Yixuan Gao6Dongmei Feng7Xiaoyong He8Chunmei Zhang9Department of Pathology, The First Affiliated Hospital of Dali UniversityDepartment of Urology Surgery, The First Affiliated Hospital of Dali UniversityDepartment of General Surgery, The First Affiliated Hospital of Dali UniversityDepartment of Pathology, The First Affiliated Hospital of Dali UniversityDepartment of Pathology, The First Affiliated Hospital of Dali UniversityDepartment of Pathology, The First Affiliated Hospital of Dali UniversityDepartment of Pathology, The First Affiliated Hospital of Dali UniversityDepartment of Pathology, The First Affiliated Hospital of Dali UniversityDepartment of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Dali UniversityDepartment of Pathology, The First Affiliated Hospital of Dali UniversityAbstract Progress in immunotherapy for prostate cancer (PCa) lags that for other cancers, mainly because of limited immune infiltration in PCa. This study aimed to assess the feasibility of NSD2 as an immunotherapeutic target in PCa. Immunohistochemistry was performed to evaluate the expression pattern of NSD2 in 34 cases of benign prostatic hyperplasia (BPH), 36 cases of prostatic intraepithelial neoplasia (PIN), and 57 cases of PCa, including 19 cases of metastatic castration-resistant prostatic cancer (mCRPC). Single-cell RNA sequencing and gene set enrichment analysis (GSEA) were used to correlate NSD2 with certain downstream pathways. Furthermore, the Immuno-Oncology-Biological-Research (IOBR) software package was used to analyze the potential roles of NSD2 in the tumor microenvironment. We found that the positive expression rate of NSD2 increased progressively in BPH, PIN and PCa. mCRPC had the highest staining intensity for NSD2. High NSD2 expression was positively correlated with the infiltration level of CD4+ tumor-infiltrating lymphocytes (TILs) and negatively correlated with that of CD8+ TILs. Importantly, a new immune classification based on NSD2 expression and CD4+ TILs and CD8+ TILs was successfully used to stratify PCa patients based on OS.PSA and CD4+ TILs are independent risk factors for PCa bone metastasis. This study demonstrates a novel role for NSD2 in defining immune infiltrate on in PCa and highlights the great potential for its application in immunotherapy response evaluation for prostate malignancies.https://doi.org/10.1038/s41598-023-48906-8
spellingShingle Qiheng Li
Jiang Zhu
Yang Zhang
Yun Pan
Zhengjin Li
Min Wang
Yixuan Gao
Dongmei Feng
Xiaoyong He
Chunmei Zhang
Association of WHSC1/NSD2 and T-cell infiltration with prostate cancer metastasis and prognosis
Scientific Reports
title Association of WHSC1/NSD2 and T-cell infiltration with prostate cancer metastasis and prognosis
title_full Association of WHSC1/NSD2 and T-cell infiltration with prostate cancer metastasis and prognosis
title_fullStr Association of WHSC1/NSD2 and T-cell infiltration with prostate cancer metastasis and prognosis
title_full_unstemmed Association of WHSC1/NSD2 and T-cell infiltration with prostate cancer metastasis and prognosis
title_short Association of WHSC1/NSD2 and T-cell infiltration with prostate cancer metastasis and prognosis
title_sort association of whsc1 nsd2 and t cell infiltration with prostate cancer metastasis and prognosis
url https://doi.org/10.1038/s41598-023-48906-8
work_keys_str_mv AT qihengli associationofwhsc1nsd2andtcellinfiltrationwithprostatecancermetastasisandprognosis
AT jiangzhu associationofwhsc1nsd2andtcellinfiltrationwithprostatecancermetastasisandprognosis
AT yangzhang associationofwhsc1nsd2andtcellinfiltrationwithprostatecancermetastasisandprognosis
AT yunpan associationofwhsc1nsd2andtcellinfiltrationwithprostatecancermetastasisandprognosis
AT zhengjinli associationofwhsc1nsd2andtcellinfiltrationwithprostatecancermetastasisandprognosis
AT minwang associationofwhsc1nsd2andtcellinfiltrationwithprostatecancermetastasisandprognosis
AT yixuangao associationofwhsc1nsd2andtcellinfiltrationwithprostatecancermetastasisandprognosis
AT dongmeifeng associationofwhsc1nsd2andtcellinfiltrationwithprostatecancermetastasisandprognosis
AT xiaoyonghe associationofwhsc1nsd2andtcellinfiltrationwithprostatecancermetastasisandprognosis
AT chunmeizhang associationofwhsc1nsd2andtcellinfiltrationwithprostatecancermetastasisandprognosis